{"id":41090,"date":"2025-09-10T16:15:34","date_gmt":"2025-09-10T08:15:34","guid":{"rendered":"https:\/\/flcube.com\/?p=41090"},"modified":"2025-09-10T16:15:35","modified_gmt":"2025-09-10T08:15:35","slug":"danaher-partners-with-beckman-to-advance-alzheimers-blood%e2%80%91biomarker-diagnosis","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=41090","title":{"rendered":"Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis"},"content":{"rendered":"\n<p>US-based science and tech services giant <strong>Danaher Corporation (<a href=\"https:\/\/www.google.com\/finance\/quote\/DHR:NYSE\">NYSE: DHR<\/a>)<\/strong> announced that its operating subsidiary, <strong>Beckman Coulter Experimental Systems (Suzhou) Co., Ltd.<\/strong> (hereafter \u201cBeckman\u201d), will collaborate with <strong>Huashan Hospital, Fudan University<\/strong> to develop next\u2011generation solutions for the <strong>early diagnosis and differential diagnosis of Alzheimer\u2019s Disease (AD)<\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-the-collaboration-at-a-glance\">The Collaboration at a Glance<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Element<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Key Players<\/strong><\/td><td>Danaher \u2011 Beckman; Huashan Hospital \u2013 Department of Neurology (Prof. Yu\u202fJintai)<\/td><\/tr><tr><td><strong>Technology Focus<\/strong><\/td><td>High\u2011sensitivity diagnostic platform for blood\u2011based biomarker panels<\/td><\/tr><tr><td><strong>Clinical Goal<\/strong><\/td><td>Correlate novel biomarkers with AD clinical outcomes to improve early detection, refine treatment plans, and delay disease progression<\/td><\/tr><tr><td><strong>Broader Impact<\/strong><\/td><td>Methods will be transferrable to other neuro\u2011degenerative and neuro\u2011immunological disorders<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-danaher-beacon-a-first-in-china\">Danaher Beacon \u2013 A First in China<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Danaher Beacon<\/strong> is a global research initiative that partners with top academic institutions to pioneer technologies that enhance human health.<\/li>\n\n\n\n<li>This partnership marks Danaher\u2019s first <strong>Beacon<\/strong> project conducted with Chinese scientists, underscoring the company\u2019s commitment to international collaboration and translational research.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-what-this-means-for-alzheimer-s-care\">What This Means for Alzheimer\u2019s Care<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Earlier Detection<\/strong> \u2013 Blood\u2011based biomarkers can identify AD before cognitive symptoms emerge, offering a window for preventive interventions.<\/li>\n\n\n\n<li><strong>Differential Diagnosis<\/strong> \u2013 Accurate biomarker panels help distinguish AD from other forms of dementia, ensuring patients receive the most appropriate therapy.<\/li>\n\n\n\n<li><strong>Patient\u2011Centric Outcomes<\/strong> \u2013 Improved diagnostic precision allows clinicians to tailor treatment plans, potentially slowing disease progression and improving quality of life.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-next-steps\">Next Steps<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pilot Studies<\/strong> \u2013 Initial validation studies will begin in Huashan Hospital\u2019s clinical cohort within the next 6\u202fmonths.<\/li>\n\n\n\n<li><strong>Regulatory Path<\/strong> \u2013 Danaher plans to engage with regulatory bodies early to align on approval pathways for the biomarker panel.<\/li>\n\n\n\n<li><strong>Expansion<\/strong> \u2013 Successful proof\u2011of\u2011concept data will be leveraged to extend the platform to other neurodegenerative indications.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced that its operating subsidiary,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":41093,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,22],"tags":[4343,30,535,1265],"class_list":["post-41090","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-medical-device","tag-beckman-coulter-experimental-systems","tag-biotech","tag-danaher","tag-nyse-dhr"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced that its operating subsidiary, Beckman Coulter Experimental Systems (Suzhou) Co., Ltd. (hereafter \u201cBeckman\u201d), will collaborate with Huashan Hospital, Fudan University to develop next\u2011generation solutions for the early diagnosis and differential diagnosis of Alzheimer\u2019s Disease (AD).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=41090\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis\" \/>\n<meta property=\"og:description\" content=\"US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced that its operating subsidiary, Beckman Coulter Experimental Systems (Suzhou) Co., Ltd. (hereafter \u201cBeckman\u201d), will collaborate with Huashan Hospital, Fudan University to develop next\u2011generation solutions for the early diagnosis and differential diagnosis of Alzheimer\u2019s Disease (AD).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=41090\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-10T08:15:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-10T08:15:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1008.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41090#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41090\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis\",\"datePublished\":\"2025-09-10T08:15:34+00:00\",\"dateModified\":\"2025-09-10T08:15:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41090\"},\"wordCount\":297,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41090#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1008.webp\",\"keywords\":[\"Beckman Coulter Experimental Systems\",\"Biotech\",\"Danaher\",\"NYSE: DHR\"],\"articleSection\":[\"Company\",\"Deals\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41090#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41090\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=41090\",\"name\":\"Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41090#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41090#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1008.webp\",\"datePublished\":\"2025-09-10T08:15:34+00:00\",\"dateModified\":\"2025-09-10T08:15:35+00:00\",\"description\":\"US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced that its operating subsidiary, Beckman Coulter Experimental Systems (Suzhou) Co., Ltd. (hereafter \u201cBeckman\u201d), will collaborate with Huashan Hospital, Fudan University to develop next\u2011generation solutions for the early diagnosis and differential diagnosis of Alzheimer\u2019s Disease (AD).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41090#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41090\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41090#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1008.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1008.webp\",\"width\":1080,\"height\":608,\"caption\":\"Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41090#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis - Insight, China&#039;s Pharmaceutical Industry","description":"US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced that its operating subsidiary, Beckman Coulter Experimental Systems (Suzhou) Co., Ltd. (hereafter \u201cBeckman\u201d), will collaborate with Huashan Hospital, Fudan University to develop next\u2011generation solutions for the early diagnosis and differential diagnosis of Alzheimer\u2019s Disease (AD).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=41090","og_locale":"en_US","og_type":"article","og_title":"Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis","og_description":"US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced that its operating subsidiary, Beckman Coulter Experimental Systems (Suzhou) Co., Ltd. (hereafter \u201cBeckman\u201d), will collaborate with Huashan Hospital, Fudan University to develop next\u2011generation solutions for the early diagnosis and differential diagnosis of Alzheimer\u2019s Disease (AD).","og_url":"https:\/\/flcube.com\/?p=41090","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-10T08:15:34+00:00","article_modified_time":"2025-09-10T08:15:35+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1008.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=41090#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=41090"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis","datePublished":"2025-09-10T08:15:34+00:00","dateModified":"2025-09-10T08:15:35+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=41090"},"wordCount":297,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=41090#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1008.webp","keywords":["Beckman Coulter Experimental Systems","Biotech","Danaher","NYSE: DHR"],"articleSection":["Company","Deals","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=41090#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=41090","url":"https:\/\/flcube.com\/?p=41090","name":"Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=41090#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=41090#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1008.webp","datePublished":"2025-09-10T08:15:34+00:00","dateModified":"2025-09-10T08:15:35+00:00","description":"US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced that its operating subsidiary, Beckman Coulter Experimental Systems (Suzhou) Co., Ltd. (hereafter \u201cBeckman\u201d), will collaborate with Huashan Hospital, Fudan University to develop next\u2011generation solutions for the early diagnosis and differential diagnosis of Alzheimer\u2019s Disease (AD).","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=41090#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=41090"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=41090#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1008.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1008.webp","width":1080,"height":608,"caption":"Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=41090#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Danaher Partners with Beckman to Advance Alzheimer\u2019s Blood\u2011Biomarker Diagnosis"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1008.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41090"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41090\/revisions"}],"predecessor-version":[{"id":41094,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41090\/revisions\/41094"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/41093"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}